Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiko Imamura

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Annals of Neurology|February 10, 2021
Prediction Model of Amyotrophic Lateral Sclerosis by Deep Learning with Patient Induced Pluripotent Stem CellsKeiko Imamura, Yuichiro Yada, Yuishin Izumi, et al.
Communications Biology|October 23, 2021
Induction of inverted morphology in brain organoids by vertical-mixing bioreactorsDang Ngoc Anh Suong, Keiko Imamura, Ikuyo Inoue, et al.
Stem Cell Research|October 17, 2017
Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutationNagahisa Murakami, Taizo Ishikawa, Takayuki Kondo, et al.
European Journal of Cell Biology|March 30, 2025
iPSC screening identifies CACNA2D2 as a potential therapeutic target for FTLD-TauKeiko Imamura, Ayako Nagahashi, Aya Okusa, et al.
Stem Cell Research|May 17, 2020
Generation of a human induced pluripotent stem cell line, BRCi005-A, derived from a Best disease patient with BEST1 mutationsKazuma Kamata, Yuki Otsuka, Keiko Imamura, et al.
Cell Reports|November 23, 2017
iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer's DiseaseTakayuki Kondo, Keiko Imamura, Misato Funayama, et al.
Stem Cell Research|May 17, 2020
Generation of a human induced pluripotent stem cell line, BRCi004-A, derived from a patient with age-related macular degenerationKazuma Kamata, Yuki Otsuka, Keiko Imamura, et al.
Iscience|April 24, 2026
Phenotypic screening of human iPSC-derived neurons identifies thienopyridones as neuritogenic small moleculesKeiko Imamura, Hiroshi Yukikate, Takeshi Hioki, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 16, 2019
High molecular weight amyloid β<sub>1-42</sub> oligomers induce neurotoxicity <i>via</i> plasma membrane damageTaro Yasumoto, Yusaku Takamura, Mayumi Tsuji, et al.
Stem Cell Research|March 9, 2019
Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type IMika Suga, Takayuki Kondo, Keiko Imamura, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Annals of Neurology|February 10, 2021
Prediction Model of Amyotrophic Lateral Sclerosis by Deep Learning with Patient Induced Pluripotent Stem CellsKeiko Imamura, Yuichiro Yada, Yuishin Izumi, et al.
Communications Biology|October 23, 2021
Induction of inverted morphology in brain organoids by vertical-mixing bioreactorsDang Ngoc Anh Suong, Keiko Imamura, Ikuyo Inoue, et al.
Stem Cell Research|October 17, 2017
Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutationNagahisa Murakami, Taizo Ishikawa, Takayuki Kondo, et al.
European Journal of Cell Biology|March 30, 2025
iPSC screening identifies CACNA2D2 as a potential therapeutic target for FTLD-TauKeiko Imamura, Ayako Nagahashi, Aya Okusa, et al.
Stem Cell Research|May 17, 2020
Generation of a human induced pluripotent stem cell line, BRCi005-A, derived from a Best disease patient with BEST1 mutationsKazuma Kamata, Yuki Otsuka, Keiko Imamura, et al.
Cell Reports|November 23, 2017
iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer's DiseaseTakayuki Kondo, Keiko Imamura, Misato Funayama, et al.
Stem Cell Research|May 17, 2020
Generation of a human induced pluripotent stem cell line, BRCi004-A, derived from a patient with age-related macular degenerationKazuma Kamata, Yuki Otsuka, Keiko Imamura, et al.
Iscience|April 24, 2026
Phenotypic screening of human iPSC-derived neurons identifies thienopyridones as neuritogenic small moleculesKeiko Imamura, Hiroshi Yukikate, Takeshi Hioki, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 16, 2019
High molecular weight amyloid β<sub>1-42</sub> oligomers induce neurotoxicity <i>via</i> plasma membrane damageTaro Yasumoto, Yusaku Takamura, Mayumi Tsuji, et al.
Stem Cell Research|March 9, 2019
Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type IMika Suga, Takayuki Kondo, Keiko Imamura, et al.
Pageof 9